Related Experiment Videos
Indicators of platelet turnover in thrombocytopenic infants
A C Sciscione1, H Bessos, N Callan
1Department of Gynaecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Insights
Newborn infants with thrombocytopenia show elevated levels of glycocalicin and interleukin-6. However, infants with intrauterine growth restriction and thrombocytopenia had no detectable glycocalicin, suggesting impaired platelet production.
Area of Science:
- Neonatal Medicine
- Hematology
- Biochemistry
Background:
- Thrombocytopenia in newborns is a significant clinical concern.
- Glycocalicin indicates platelet turnover, and interleukin-6 (IL-6) may rise with low platelet counts.
- Understanding the mechanisms of neonatal thrombocytopenia is crucial.
Purpose of the Study:
- To investigate the pathophysiology of thrombocytopenia in newborn infants.
- To evaluate glycocalicin and IL-6 as markers in neonatal thrombocytopenia.
- To explore the relationship between intrauterine growth restriction (IUGR) and thrombocytopenia.
Main Methods:
- Cord blood samples were collected from 499 infants.
- Platelet counts were determined for all infants.
- Enzyme-linked immunosorbent assays (ELISA) were performed for IL-6 and glycocalicin.
Main Results:
- Thrombocytopenic infants (< 100,000/mm3) exhibited elevated mean levels of glycocalicin and IL-6 compared to controls.
- Infants with both IUGR and thrombocytopenia showed undetectable glycocalicin.
- Elevated IL-6 levels were observed in infants with IUGR and thrombocytopenia.
Conclusions:
- Elevated glycocalicin and IL-6 suggest increased platelet destruction or turnover in neonatal thrombocytopenia.
- The absence of detectable glycocalicin in infants with IUGR and thrombocytopenia points to impaired thrombopoiesis.
- IL-6 may serve as a marker for the inflammatory response in neonatal thrombocytopenia, even with compromised platelet production.
Abstract:
Glycocalicin has been found to be a marker of increased platelet turnover, while interleukin-6 may be increased in response to thrombocytopenia. We used these markers to study the pathophysiology of thrombocytopenia in newborn infants. Cord blood platelet counts were obtained from 499 infants. Thrombocytopenic infants (< 100,000/mm3) and a control group had ELISA assays for interleukin-6 and glycocalicin performed. The mean levels of glycocalicin and interleukin-6 were elevated in cord blood of thrombocytopaenic infants. Infants with intrauterine growth restriction and thrombocytopaenia had no detectable glycocalicin in their plasma, despite elevated levels of interleukin-6. This probably reflects impaired thrombopoiesis in these infants.